checkAd

    EQS-Adhoc  105  0 Kommentare General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase

    Für Sie zusammengefasst
    • General partner plans dividend increase
    • Dividend per share to increase to EUR 1.00
    • Full Annual Report for 2023 to be published on March 28, 2024

    EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend
    General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase

    20-Feb-2024 / 20:35 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase

    Anzeige 
    Handeln Sie Ihre Einschätzung zu CompuGroup Medical!
    Long
    26,82€
    Basispreis
    0,20
    Ask
    × 14,27
    Hebel
    Short
    30,18€
    Basispreis
    0,22
    Ask
    × 12,97
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Against the background of the stable financial and earnings position the general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend payment to a higher level. Therefore, the general partner plans to propose to the Annual General Meeting to increase the dividend per dividend bearing share to EUR 1.00 for the financial year 2023, compared to a dividend of EUR 0.50 per share for the financial year 2022.

    The proposed dividend increase will be on the agenda of the Supervisory Board after the final financial statements for the financial year 2023 are available.

    A dividend payment based on the final dividend proposal of the general partner and the Supervisory Board for the financial year 2023 is subject to the approval of the Annual General Meeting as well as further legal requirements.

    CompuGroup Medical SE & Co. KGaA will publish the full Annual Report for the financial year 2023 as planned on March 28, 2024.

     

     



    End of Inside Information

    20-Feb-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: CompuGroup Medical SE & Co. KGaA
    Maria Trost 21
    56070 Koblenz
    Germany
    Phone: +49 (0)160 3630362
    Fax: +49 (0)261 8000 3200
    E-mail: investor@cgm.com
    Internet: www.cgm.com
    ISIN: DE000A288904
    WKN: A28890
    Indices: SDAX, TecDAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1841405

     
    End of Announcement EQS News Service

    1841405  20-Feb-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1841405&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e 

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase 20-Feb-2024 / 20:35 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the …

    Schreibe Deinen Kommentar

    Disclaimer